CRISPRQC INC. — Form D/A
CRISPRQC INC. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2024-02-29. The offering totals $10.0M, of which $945K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-29
- Form: D/A
- Accession: 0001916528-24-000002
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $10.0M
- Amount sold: $945K
- Remaining: $9.1M
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2024-01-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-506176
Issuer
- Name: CRISPRQC INC.
- CIK: 0001916528
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 8949 KENAMAR DR, SAN DIEGO, CA, 92121
- Phone: (858) 444-0037
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Ross Bundy | Director | San Diego, CA |
| Ross Bundy | Executive Officer | San Diego, CA |
| George Bonaros | Director | San Diego, CA |
| Paul Grint | Director | San Diego, CA |
| Kiana Aran | Director | San Diego, CA |
| Toby Richardson | Director | San Diego, CA |
| Chris Yoo | Director | San Diego, CA |
| Michael Heltzen | Director | San Diego, CA |
| Ross Helgren Bundy | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More